Surfactant Administration Methods in Preterm Infants With RDS: A Swedish Cohort Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorVastra Gotaland Region

About this trial

The goal of this observational study is to evaluate different methods of surfactant administration in preterm infants with respiratory distress syndrome (RDS). Preterm infants often have immature lungs and a deficiency of surfactant, a substance that helps keep the lungs open and supports oxygen exchange.Surfactant can be delivered to the lungs using different techniques, including INSURE (brief intubation), LISA (via a thin catheter), SALSA (via a laryngeal mask airway), and traditional administration via endotracheal intubation followed by mechanical ventilation. The main question this study aims to answer is:Which method of surfactant administration is associated with better clinical outcomes in preterm infants with RDS?The study will prospectively collect clinical data on infants receiving surfactant as part of standard care, with long-term follow-up using data from the Swedish Neonatal Quality Register. The results are intended to be used to inform the design of a future randomized multicenter study.

Eligibility criteria

Qualifiers

Patient has received surfactant by any administration method

Gestational age below 37 weeks'

First surfactant treatment given before 48 hours of age

Confirmed or suspected diagnosis of respiratory distress syndrome (RDS)

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

300 Participants
are grouped into 4 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Vastra Gotaland Region

Lead sponsor

Göteborg University

Collaborator